Navigation Links
OmniComm Systems Announces 1st Quarter Results of Operations
Date:4/23/2009

FORT LAUDERDALE, Fla., April 22 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM) a leader in integrated eClinical solutions for the clinical trials market today announced its results of operations for the first quarter of fiscal 2009.

Revenue for the first quarter of 2009 increased approximately 139% to $2,416,600 compared to $1,012,000 in the same period of 2008. Gross profit margin improved to 79.5% for the three months ended March 31, 2009 compared to 68.5% for the comparable period in 2008. The improvement in the Company's gross profit margin reflects the significant increase in revenue which can be attributed to success in broadening the overall revenue mix through the deployment of TrialMaster(TM) on a licensed basis. In conjunction with the licensing of TrialMaster, the Company also increased the revenues it recognized from professional and consulting services during the first quarter of 2009.

As of March 31, 2009, the Company's balance sheet reflected total assets of approximately $4.5 million, and cash of $2.1 million. The Company experienced a net increase in cash during the first quarter of 2009 and a slight decrease in its net working capital position at March 31, 2009.

"We feel that our first quarter results are indicative of the fact that our infrastructure investments from the last two years have allowed us to make great strides in the eClinical market. The market in general is experiencing some signs of the economic difficulties being felt across the economy. In particular, small biotechnology firms have slowed the rate of EDC spending and our CRO partners are experiencing higher levels of cancellations than expected. However, we are seeing increased activity in our European operations and are encouraged to see that the market for technology transfers has picked up. We believe that OmniComm is positioned to capture additional market share once clinical trial activity begins to rebound. We are pleased that we were able to maintain our S, G & A at levels comparable to 2008, increase our gross profit margins while growing our revenues substantially. By increasing our revenues and successfully managing our costs we have managed to maintain our operating cash. This has allowed us to maintain our financial position in a difficult economy. We have evaluated our cost structure in light of our existing business development pipeline and taken measures to ensure that we optimize the use of our financial resources," commented Ronald T. Linares, Chief Financial Officer of the Company.

"We believe that we are well positioned to grow our business during 2009," said Cornelis F. Wit, Chief Executive Officer of the Company. "Our strategy has been to build the strongest management team possible and to position our products to provide the depth and breadth of functionality and service our clients need to successfully bring their therapies to market. During 2009, our focus will be on increasing our market penetration, increasing revenues from the spectrum of products and services we offer and maintaining a tight handle on our operating expenses. The core of both our long-term strategic and near-term operating plans is ensuring that we continue to provide existing and potential clients cutting-edge eClinical solutions coupled with an emphasis on value-added professional and consulting services."

About OmniComm

OmniComm Systems, Inc. (www.OmniComm.com) provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm's client intuitive pricing model allows companies that range from small, to mid-size to large scale institutions to safely and efficiently capitalize on their clinical research investments. OmniComm Systems, Inc. has corporate headquarters in Ft. Lauderdale, Florida with offices in Bonn, Chicago, Germany, Tula, Russia, California, New York, North Carolina, Tennessee, Massachusetts and Georgia.

Safe Harbor Disclaimer

Statements about OmniComm's future expectations, including without limitation, future revenues and earnings, plans and objectives for the future operations, future agreements, future economic performance, operations and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. OmniComm intends that such forward-looking statements be subject to the Safe Harbors created thereby. Since these statements involve risks and uncertainties, including but not limited to economic competitive, governmental, contractual and technological factors affecting OmniComm's operations, markets and profitability, actual results could differ materially and adversely from the expected results.


'/>"/>
SOURCE OmniComm Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. OmniComm Systems, Inc. Is Fueled by Another Strong Quarter Delivering Electronic Data Capture (EDC) Solutions & Services
2. OmniComm Systems, Inc. Experiences Record Year End Results - $18 Million in Signed Contracts for the Year 2008
3. OmniComm Systems Announces Settlement of Patent Litigation With DataSci, LLC
4. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
5. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
6. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
7. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
8. NxStage Medical Provides Update on Medisystems Acquisition
9. ICx Awarded $1.5 M Contract by Department of Homeland Security for Development of Next Generation Bio Aerosol Systems
10. Imaging Diagnostic Systems New Laser Breast Imaging Scanner Introduced in Malaysia
11. Varian Medical Systems Exhibits Latest Technologies and Products Designed to Improve Speed and Precision of Radiotherapy at ESTRO 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016  Sequenom, Inc. (NASDAQ: SQNM ... lives through the development of innovative products and services, ... the United States denied its petition to ... of Sequenom,s U.S. Patent No. 6,258,540 (",540 Patent") are ... by the Supreme Court,s Mayo Collaborative Services v. Prometheus ...
(Date:6/27/2016)... , ... June 27, 2016 , ... Parallel 6 ... trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which ... with the physician and clinical trial team. , Using the CONSULT module, patients and ...
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf ... join the faculty of the University of North Carolina Kenan-Flagler Business School ... and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s international efforts, ...
(Date:6/27/2016)... , June 27, 2016   Ginkgo Bioworks , ... industrial engineering, was today awarded as one of ... of the world,s most innovative companies. Ginkgo Bioworks ... for the real world in the nutrition, health ... work directly with customers including Fortune 500 companies ...
Breaking Biology Technology:
(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... provide their customers enhanced security to access and ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
Breaking Biology News(10 mins):